Interferon alpha-n1

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha-n1
Drug Alias NameInterferon alfa-n1 (GlaxoSmithKline)Wellferon
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionImmunomodulatorsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsRespiratory papillomatosisLeukemia, Myelogenous, ChronicLeukemia, Hairy Cell +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRespiratory papillomatosisLeukemia, Myelogenous, ChronicLeukemia, Hairy Cell +[6] 

Other Information

ATC CodeL03AB06
Related LinksN/A